AV Coronary Intervention Group
Device
Abbott Laboratories
Total Payments
$476,153
Transactions
8
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $6,589 | 2 | 0 |
| 2019 | $469,564 | 6 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $476,153 | 8 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Drug Eluting Stent Trials Pooling Project | Abbott Laboratories | $341,160 | 0 |
| Long-term Outcomes and Resource Utilization Associated with Target vessel Failure | Abbott Laboratories | $128,404 | 0 |
| Abbott Infrapopliteal Vessel Sizing Project | Abbott Laboratories | $5,000 | 0 |
| Abbott Vascular Medical Device Registry | Abbott Laboratories | $1,589 | 0 |
Top Doctors Receiving Payments for AV Coronary Intervention Group
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $476,153 | 8 |
Ad
Manufacturing Companies
- Abbott Laboratories $476,153
Product Information
- Type Device
- Total Payments $476,153
- Total Doctors 0
- Transactions 8
About AV Coronary Intervention Group
AV Coronary Intervention Group is a device associated with $476,153 in payments to 0 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2020. In 2020, $6,589 was paid across 2 transactions to 0 doctors.
The most common payment nature for AV Coronary Intervention Group is "Unspecified" ($476,153, 100.0% of total).
AV Coronary Intervention Group is associated with 4 research studies, including "Drug Eluting Stent Trials Pooling Project" ($341,160).